Investigating the effect of a mHealth assisted allied health opioid tapering intervention on daily opioid use for chronic pain: the MOTION-Pilot randomised controlled trial

Not Applicable

• Conditions: Chronic Pain; Anaesthesiology - Pain management; Public Health - Health service research

• Registration Number: ACTRN12624000745549
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-17
• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients will be eligible to participate in the trial if they: i) have a pain duration equal to or greater than 3 months, ii) are aged 18 - 80 years, iii) have non-malignant pain, iv) are prescribed opioids, and v) are open to engaging with allied health staff to discuss their pain medications.

Exclusion Criteria

Individuals will be excluded if they: i) cannot communicate in English, ii) have a significant intellectual or cognitive impairment, iii) have active psychosocial issues including suicidal intent, or psychosis, iv) intravenous drug use, v) are currently using any implanted device for pain control (e.g., intrathecal pump, spinal cord stimulator, peripheral nerve stimulator), vi) have had surgery within the previous month or have surgery planned during the next 6 months and vii) evidence of recent aberrant drug-related behaviours (i.e. stealing or borrowing drugs from others, altering mode of administration of drug delivery and aggressive complaints about the need for more medication)

Study & Design

• Study Type: Interventional
• Study Design: Not specified